Abstract
Isoprenylcysteine methyltransferase (Icmt) catalyzes the carboxyl methylation of oncogenic proteins in the final step of a series of post-translational modifications. The inhibition of Icmt provides an attractive and novel anticancer target. A natural product high-throughput screening campaign was conducted to discover inhibitors of Icmt. The Australian marine sponge, Pseudoceratina sp., yielded spermatinamine, a novel alkaloid with a bromotyrosyl-spermine-bromotyrosyl sequence, as the bioactive constituent. Its structure was determined by 1D and 2D NMR spectroscopy. Spermatinamine is the first natural product inhibitor of Icmt.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / toxicity*
-
Biological Products / chemistry*
-
Biological Products / toxicity*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / toxicity
-
Magnetic Resonance Spectroscopy
-
Molecular Structure
-
Neoplasms / enzymology*
-
Neoplasms / pathology
-
Protein Methyltransferases / antagonists & inhibitors*
-
Protein Methyltransferases / metabolism
-
Spermine / analogs & derivatives*
-
Spermine / chemistry
-
Spermine / toxicity
-
Tyrosine / analogs & derivatives*
-
Tyrosine / chemistry
-
Tyrosine / toxicity
Substances
-
Antineoplastic Agents
-
Biological Products
-
Enzyme Inhibitors
-
spermatinamine
-
Spermine
-
Tyrosine
-
Protein Methyltransferases
-
protein-S-isoprenylcysteine O-methyltransferase